학술논문

A kinase inhibitor screen reveals MEK1/2 as a novel therapeutic target to antagonize IGF1R-mediated antiestrogen resistance in ERa-positive luminal breast cancer
Document Type
Journal
Source
BIOCHEMICAL PHARMACOLOGY; OCT 2022, 204 p115233 18p.
Subject
Language
English
ISSN
18732968